On March 20, 2024, Perceptive Advisors LLC announced that representatives of Perceptive Advisors have discussed with Rhythm Pharmaceuticals, Inc potential financing options, possibly involving additional investment by Perceptive Advisors and other investors, and potential governance rights of investors participating in such financing arrangements. Perceptive Advisors also stated that there is no certainty that these discussions will continue, or that any specific plan will develop or materialize, or if one does, its timing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.28 USD | +0.34% | +0.71% | -16.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.73% | 2.33B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RYTM Stock
- News Rhythm Pharmaceuticals, Inc.
- Perceptive Advisors Engages in Discussion with Rhythm Pharmaceuticals